P53 gene polymorphisms and breast cancer risk in Arab women

Medical Oncology

Volumn 28, Issue 3, 2011, Pages 709-715

  Alawadi, Shafika ^a,b   Ghabreau, Lina ^c   Alsaleh, Mervat ^a   Abdulaziz, Zainab ^b   Rafeek, Mohamed ^a   Akil, Nizar ^c   Alkhalaf, Moussa ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

^b KUWAIT CANCER CONTROL CENTER   (Kuwait)

^c UNIVERSITY OF ALEPPO   (Syrian Arab Republic)

Author keywords

Arab; Breast cancer risk; Codon 47; Codon 72; Kuwait; P53 polymorphisms; Syria

Indexed keywords

ARGININE; PROLINE; PROTEIN P53; SERINE;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER RISK; CODON; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENE INSERTION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HOMOZYGOSITY; HUMAN; INTRON; KUWAIT; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; SYRIAN ARAB REPUBLIC; TUMOR SUPPRESSOR GENE; WILD TYPE;

ARABS; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RISK FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84856907939     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-010-9505-4     Document Type: Article

References (32)

1. KH Vousden DP Lane 2007 P53 in health and disease Nat Rev Mol Cell Biol 8 275 283 17380161 10.1038/nrm2147 1:CAS:528:DC%2BD2sXjtlygsr0%3D
2. B Vogelstein D Lane AJ Levine 2000 Surfing the p53 network Nature 408 307 310 11099028 10.1038/35042675 1:CAS:528:DC%2BD3cXosVemtrY%3D
3. A Petitjean E Mathe S Kato C Ishioka SV Tavtigian, et al. 2007 Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database Hum Mutat 28 622 629 17311302 10.1002/humu.20495 1:CAS:528:DC%2BD2sXmsVymur8%3D
4. C Whibley PD Pharoah M Hollstein 2009 p53 polymorphisms: cancer implications Nat Rev Cancer 9 95 107 19165225 10.1038/nrc2584 1:CAS:528:DC%2BD1MXpsVCntg%3D%3D
5. E Felley-Bosco A Weston HM Cawley WP Bennett CC Harris 1993 Functional studies of a germ-line polymorphism at codon 47 within the p53 gene Am J Hum Genet 53 752 759 8352280 1:CAS:528:DyaK2cXht1KltbY%3D
6. GJ Matlashewski S Tuck D Pim P Lamb J Schneider LV Crawford 1987 Primary structure polymorphism at amino acid residue 72 of human p53 Mol Cell Biol 7 961 963 3547088 1:CAS:528:DyaL2sXhtlarsLo%3D
7. P Dumont JI Leu AC Della Pietra 3rd DL George M Murphy 2003 The codon 72 polymorphic variants of p53 have markedly different apoptotic potential Nat Genet 33 357 365 12567188 10.1038/ng1093 1:CAS:528:DC%2BD3sXhsV2ktbc%3D
8. M Siddique K Sabapathy 2006 Trp53-dependent DNA-repair is affected by the codon 72 polymorphism Oncogene 25 3489 3500 16462765 10.1038/sj.onc.1209405 1:CAS:528:DC%2BD28Xls1Kis7g%3D
9. P Sansone G Storci S Pandolfi L Montanaro P Chieco M Bonafe 2007 The p53 codon 72 proline allele is endowed with enhanced cell-death inducing potential in cancer cells exposed to hypoxia Br J Cancer 96 1302 1308 17406354 10.1038/sj.bjc.6603723 1:CAS:528:DC%2BD2sXkt1Gqtbg%3D
10. A Själander R Birgander G Hallmans S Cajander P Lenner, et al. 1996 p53 polymorphisms and haplotypes in breast cancer Carcinogenesis 17 1313 1316 8681448 10.1093/carcin/17.6.1313
11. A Langerød IR Bukholm A Bregård PE Lønning TI Andersen, et al. 2002 The TP53 codon 72 polymorphism may affect the function of TP53 mutations in breast carcinomas but not in colorectal carcinomas Cancer Epidemiol Biomarkers Prev 11 1684 1688 12496062
12. Zhang Z, Wang M, Wu D, Wang M, Tong N, et al. P53 codon 72 polymorphism contributes to breast cancer risk: a meta-analysis based on 39 case-control studies. Breast Cancer Res Treat. 2009 Jul 23. [Epub ahead of print].
13. K Suzuki H Matsui N Ohtake S Nakata T Takei, et al. 2003 p53 codon 72 polymorphism associated with prostate cancer development and progression in Japanese J Biomed Sci 10 430 435 12824702 10.1007/BF02256434 1:CAS:528:DC%2BD3sXkvVegs7s%3D
14. F Granja J Morari EC Morari LA Correa LV Assumpção LS Ward 2004 Proline homozygosity in codon 72 of p53 is a factor of susceptibility for thyroid cancer Cancer Lett 210 151 157 15183530 10.1016/j.canlet.2004.01.016 1:CAS:528:DC%2BD2cXks1WrsLs%3D
15. B Hadhri-Guiga N Toumi A Khabir T Sellami-Boudawara A Ghorbel, et al. 2007 Proline homozygosity in codon 72 of TP53 is a factor of susceptibility to nasopharyngeal carcinoma in Tunisia Cancer Genet Cytogenet 178 89 93 17954263 10.1016/j.cancergencyto.2007.05.013 1:CAS:528:DC%2BD2sXhtF2lsr3F
16. EN Suspitsin KG Buslov MY Grigoriev JG Ishutkina JM Ulibina, et al. 2003 Evidence against involvement of p53 polymorphism in breast cancer predisposition Int J Cancer 103 431 433 12471629 10.1002/ijc.10834 1:CAS:528: DC%2BD3sXht1yhsg%3D%3D
17. G De Vecchi P Verderio S Pizzamiglio S Manoukian L Bernard, et al. 2008 The p53 Arg72Pro and Ins16 bp polymorphisms and their haplotypes are not associated with breast cancer risk in BRCA-mutation negative familial cases Cancer Detect Prev 32 140 143 18640791 10.1016/j.cdp.2008.06.003
18. A Marsh AB Spurdle BC Turner S Fereday H Thorne, et al. 2001 The intronic G13964C variant in p53 is not a high-risk mutation in familial breast cancer in Australia Breast Cancer Res 3 346 349 11597326 10.1186/bcr319 1:CAS:528:DC%2BD3MXntlegtrw%3D
19. R Hrstka M Beranek K Klocova R Nenutil B Vojtesek 2009 Intronic polymorphisms in TP53 indicate lymph node metastasis in breast cancer Oncol Rep 22 1205 1211 19787241 1:CAS:528:DC%2BD1MXhtlCjtb3O
20. S Wang-Gohrke H Becher R Kreienberg IB Runnebaum J Chang-Claude 2002 Intron 3 16 bp duplication polymorphism of p53 is associated with an increased risk for breast cancer by the age of 50 years Pharmacogenetics 12 269 272 11927843 10.1097/00008571-200204000-00012 1:CAS:528:DC%2BD38XnsFKqsb8%3D
21. N Buyru J Altinisik S Demokan N Dalay 2007 p53 genotypes and haplotypes associated with risk of breast cancer Cancer Detect Prev 3 207 213 10.1016/j.cdp.2007.04.004
22. S Costa D Pinto D Pereira H Rodrigues J Cameselle-Teijeiro, et al. 2008 Importance of TP53 codon 72, intron 3 duplication 16 bp polymorphisms in prediction of susceptibility on breast cancer BMC Cancer 8 32 18230179 10.1186/1471-2407-8-32
23. M Franeková P Zúbor A Stanclová CA Dussan T Bohusová, et al. 2007 Association of p53 polymorphisms with breast cancer: a case-control study in Slovak population Neoplasma 54 155 161 17319790
24. Ł Fiszer-Maliszewska B Kazanowska P Kuśnierczyk M Mańczak W Niepiekło, et al. 2003 Is p53 intronic variant G13964C associated with predisposition to cancer? J Appl Genet 44 547 552 14617836
25. Y Xu L Yao T Ouyang J Li T Wang, et al. 2005 p53 Codon 72 polymorphism predicts the pathologic response to neoadjuvant chemotherapy in patients with breast cancer Clin Cancer Res 11 7328 7333 16243804 10.1158/1078-0432.CCR-05- 0507 1:CAS:528:DC%2BD2MXhtFartbrN
26. M Alkhalaf S Al-Bustan H Hamoda N Abdella 2007 Polymorphism of p53 gene codon 72 in Kuwaiti with coronary artery disease and diabetes Int J Cardiol 115 1 6 16797751 10.1016/j.ijcard.2006.01.029
27. Akkiprik M, Sonmez O, Gulluoglu BM, Caglar HB, Kaya H, et al. Analysis of p53 Gene Polymorphisms and Protein Over-expression in Patients with Breast Cancer. Path Oncol Res. 2008. doi: 10.1007/s12253-008-9129-6.
28. G Beckman R Birgander A Sjalander N Saha PA Holmberg, et al. 1994 Is p53 polymorphism maintained by natural selection? Hum Hered 44 266 270 7927355 10.1159/000154228 1:STN:280:DyaK2M%2Fht1anuw%3D%3D
29. V Singh N Rastogi N Mathur K Singh MP Singh 2008 Association of polymorphism in MDM-2 and p53 genes with breast cancer risk in Indian women Ann Epidemiol 18 48 57 17719241 10.1016/j.annepidem.2007.06.006
30. B Khadang MJ Fattahi A Talei AS Dehaghani A Ghaderi 2007 Polymorphism of TP53 codon 72 showed no association with breast cancer in Iranian women Cancer Genet Cytogenet 173 38 42 17284368 10.1016/j.cancergencyto.2006.09.010 1:CAS:528:DC%2BD2sXhtlCks78%3D
31. L Cavallone SL Arcand C Maugard P Ghadirian AM Mes-Masson, et al. 2008 Haplotype analysis of TP53 polymorphisms, Arg72Pro and Ins16, in BRCA1 and BRCA2 mutation carriers of French Canadian descent BMC Cancer 8 96 18402691 10.1186/1471-2407-8-96
32. I Vannini W Zoli A Tesei M Rosetti P Sansone, et al. 2008 Role of p53 codon 72 arginine allele in cell survival in vitro and in the clinical outcome of patients with advanced breast cancer Tumour Biol 29 145 151 18612219 10.1159/000143400 1:CAS:528:DC%2BD1cXhtV2isbbL